A new study analyzes death risk from COVID-19 in organ transplant recipients

Source: Michigan Health Lab

A new study, published in Transplantation, finds that risk of death from COVID-19 in organ transplant recipients may be based upon how the patient was treated.“

The research team found that disease severity and intubation rates were similar among both solid organ transplant recipients and non-transplant patients, but organ transplant recipients needed more renal replacement therapy, which takes over functioning for the kidneys when they are failing.

While death due to severity of the virus was similar in both groups, the use of hydroxychloroquine treatment was associated with higher death rates among the organ transplant recipients.

Read the article.

Previous
Previous

COVID-19 infection in kidney transplant recipients at the epicenter of pandemics

Next
Next

Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study